xevinapant

Merck
Uncategorized

Merck KGaA Expects 2023 Profit to Slip As COVID Demand Wanes

Germany’s Merck KGaA on Thursday predicted 2023 earnings would slip due to a decline at its electronic chemicals unit and a drop in COVID-related demand for its lab supplies from drug and vaccine makers. For 2023 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, the company “assumes a moderate decline to an […]

Related Posts
Global banks raise forecast to 4% peak for key ECB rate

Goldman Sachs (NYSE:GS), BNP Paribas (OTC:BNPQY), Uncredited (BIT:CRDI) and RBC Capital Markets had earlier expected the ECB’s terminal rate to Read more

4 Big Analyst Picks: Accenture Upgraded To Neutral Ahead of Q3 Earnings

Earlier this week, the company announced a $3 billion investment over three years in its Data & AI practice. The Read more

Toyota Wins Over Shareholders at AGM After Questions On Strategy, Governance

Toyota shareholders backed the board and voted down the first resolution proposed in 18 years at an annual general meeting Read more

Nikkei Closes Above 33,000 For The First Time In 33 Years

Japan’s benchmark Nikkei gauge surged on Tuesday, closing over 33,000 for the first time in 33 years, led by technology Read more

Read More